BioCentury
ARTICLE | Clinical News

DTaP: Was advised by the NIH that a Phase III trial

September 26, 1994 7:00 AM UTC

North American Vaccine Inc. (NVX), Beltsville, Md. Product: DTaP vaccine for diphtheria, tetanus, and whooping cough (pertussis) Indication: Childhood immunization Status: Was advised by the NIH that ...